Yuhan

Pharma

Merck-Kelun, China deal wisdom, Takeda—Fierce Pharma Asia

Merck and Kelun's sac-TMT reported three positive phase 3s. Experts talk useful tools in China dealmaking. Takeda was hit with a pay-for-delay verdict.

Angus Liu May 22, 2026 8:53am

People shaking hands across a desk that has computer and papers on it

Gilead, Yuhan expand partenership with $140M API contract

May 20, 2026 9:57am

Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia

Mar 28, 2025 9:28am

A $410M obesity debut, Legend, BeiGene and more—Fierce Pharma Asia

Jan 10, 2025 9:00am

Lilly, Gilead-Yuhan, Leqembi—Fierce Pharma Asia

Oct 18, 2024 8:20am

Daiichi, Fosun, Yuhan and more—Fierce Pharma Asia

Sep 27, 2024 10:15am